Related Experiment Videos
Peripheral blood versus bone marrow for hematopoietic cell transplantation
1University of Minnesota, Department of Medicine, Minneapolis 55455, USA.
Current Opinion in Oncology
|April 29, 1998
Summary
Peripheral blood stem cell transplantation is increasingly common. While cytokine-mobilized apheresis is effective, differences in graft composition and immune recovery compared to bone marrow transplantation require further study, especially regarding graft-versus-host disease incidence.
Area of Science:
- Hematology
- Immunology
- Transplantation Medicine
Background:
- Peripheral blood stem cell transplantation (PBSCT) is increasingly utilized in autologous and allogeneic settings.
- Cytokine use has enabled peripheral stem cell procurement via apheresis, offering an alternative to bone marrow harvesting.
Purpose of the Study:
- To highlight the growing use of PBSCT.
- To underscore the need for comparative analysis between PBSCT and bone marrow transplantation (BMT).
- To identify knowledge gaps regarding graft composition, immune reconstitution, and graft-versus-host disease (GVHD).
Main Methods:
- Review of current practices in stem cell mobilization and procurement.
- Comparative analysis of graft characteristics from peripheral blood versus bone marrow.
- Assessment of immune reconstitution post-transplantation.
- Identification of data gaps concerning GVHD incidence.
Main Results:
- Apheresis, supported by cytokines, is a viable method for peripheral stem cell collection.
- Distinct differences exist in graft composition between PBSCT and BMT.
- Post-transplantation immune reconstitution varies between PBSCT and BMT.
Conclusions:
- PBSCT is a frequent alternative to BMT.
- Further research is necessary to fully understand the implications of graft composition and immune recovery differences.
- Reliable data on comparative acute and chronic graft-versus-host disease incidence following allogeneic PBSCT versus BMT are currently lacking.